Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense

October 17, 2019

MONTREAL, Oct. 17, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly- owned subsidiary, Biocannabix (“BCX”), has executed an Agreement (the...

Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix

September 19, 2019

MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new, publicly-traded company through a spin-out of its pediatric,...

Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters

September 11, 2019

MONTREAL, Sept. 11, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the results of the Company’s annual general and special meeting (the...

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

August 1, 2019

MONTREAL, Aug. 01, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company hit a record high in monthly sales in the month of July 2019 for its...

Cannabis Cultivation and Extraction Potentially Costs 80% Less in Latin America

June 26, 2019

PALM BEACH, Florida, June 26, 2019 /PRNewswire/ — A recent article in the Green Fund said that: “The global cannabis market is thought to be worth USD$150 billion today (March 15, 2019). Barclays, in their European Consumer Staples Report in September...